Trial · NCT04406714
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75) | Up to 6 months after randomization | Subjects who actively receive health care from the study sites, aged between 50-75. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Proportion of Subjects Who Returned a Completed Mailed FIT at 60 Days | Up to 60 days after randomization | Subjects who actively receive health care from the study sites, aged between 50-75. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Proportion of Subjects Who Completed a Follow-up (Diagnostic) Colonoscopy | Up to 6 months after diagnostic colonoscopy referral date | Subjects who started the study and were assessed for colon carcinoma within 6 months. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Subject Colorectal Carcinoma (CRC) and Advanced Adenomas Detected at 12 Months | Up to 12 months after screening or diagnostic colonoscopy result date | Subjects who participated to the study and were diagnosed with colorectal carcinoma. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Days From CRC Diagnosis to the Date of Evaluation for CRC Treatment | Up to 12 months after CRC diagnosis | Participants were diagnosed with CRC ever during Round 1. Five subjects from Trial Mailed FIT Intervention - Age Group 50-75 and 2 subjects from Trial Usual Care - Age Group 50-75 were evaluated for treatment. | days | MEAN |
| SECONDARY | Number of Subjects Who Received Referral for Cancer Treatment | Up to 6 months after cancer diagnosis date | Subjects who received a referral for cancer treatment. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Subjects Mailed FITs Completed After Two Rounds of Annual FIT Outreach | Round 1 time frame: at 6 months after randomization; Round 2 time frame: at 6 months after determining eligibility for Round 2 | Subjects who are 50-75 years old received study intervention. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Incremental Cost of Each Additional Patient Screened in the Intervention Arm Compared to Usual Care (Trial - Age Group 50-75) | Through study completion, up to 36 months after randomization | |||
| SECONDARY | The Proportion of Subjects, Ages 45-49, Who Are Current With CRC Screening | Up to 6 months after randomization | Screening-eligible population, aged 45-49 years old. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Proportion of Subjects, Ages 45-49, Who Completed Mailed FIT at 60 Days | 60 days after randomization | Subjects who are between 45-49 old completed mailed FIT at 60 days | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Proportion of Subjects Who Completed a Follow up (Diagnostic) Colonoscopy | Up to 6 months after abnormal FIT result date | Subjects who are 45-49 years old completed study intervention. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04406714/outcomes